Keros Therapeutics Expects Cash and Cash Equivalents on Hand at March 31 Will Fund Expenses and Cap Expenditure Requirements Into 2027 >KROS
Keros Therapeutics Expects Cash and Cash Equivalents on Hand at March 31 Will Fund Expenses and Cap Expenditure Requirements Into 2027 >KROS
Keros Therapeutics预计，截至3月31日手头的现金和现金等价物将为2027年的支出和上限支出要求提供资金 >KROS
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册